X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-22 | SION | Sionna Therapeutics, Inc. | Tpg Gp A, LLC | 10% | S - Sale | $40.00 | -250,000 | 6,494,962 | -4% | -$10,000,000 | ||||||
2026-01-22 | DSP | Viant Technology Inc. | Madden Larry | CFO | S - Sale | $13.09 | -4,224 | 405,554 | -1% | -$55,286 | ||||||
| M | 2026-01-22 | CXH | Mfs Investment Grade Municipal Trust | Bulldog Investors, LLP | 10% | P - Purchase | $7.97 | +10,119 | 12,907 | +363% | +$80,648 | |||||
2026-01-22 | CXH | Mfs Investment Grade Municipal Trust | Bulldog Investors, LLP | 10% | S - Sale | $7.97 | -5,000 | 12,907 | -28% | -$39,850 | ||||||
| M | 2026-01-22 | USIO | Usio, Inc. | National Services, Inc | 10% | S - Sale | $1.35 | -16,445 | 2,760,040 | -1% | -$22,275 | |||||
2026-01-22 | LNWO | Light & Wonder, Inc. | Fine Capital Partners, L.P. | 10% | S - Sale | $116.29 | -5,694 | 8,160,992 | 0% | -$662,141 | ||||||
2026-01-26 | MDGL | Madrigal Pharmaceuticals, Inc. | Sibold William John | Pres, CEO | S - Sale | $492.42 | -1,577 | 148,497 | -1% | -$776,546 | ||||||
2026-01-26 | MDGL | Madrigal Pharmaceuticals, Inc. | Taub Rebecca | Dir | S - Sale | $492.42 | -647 | 1,108,244 | 0% | -$318,596 | ||||||
| M | 2026-01-22 | ANF | Abercrombie & Fitch Co /De/ | Horowitz Fran | CEO | S - Sale | $96.99 | -203,200 | 505,303 | -29% | -$19,708,347 | |||||
| M | 2026-01-22 | IBKR | Interactive Brokers Group, Inc. | Nemser Earl H | Vice COB | S - Sale | $77.43 | -245,000 | 606,830 | -29% | -$18,969,682 | |||||
| DM | 2026-01-22 | UWMC | Uwm Holdings Corp | Mat Ishbia | Pres, CEO, 10% | S - Sale+OE | $5.82 | -1,898,622 | 3,701,002 | -34% | -$11,056,309 | |||||
| D | 2026-01-26 | EOSE | Eos Energy Enterprises, Inc. | Kroeker Nathan | CCO, Interim CFO | S - Sale+OE | $16.04 | -50,000 | 662,512 | -7% | -$802,000 | |||||
2026-01-22 | RF | Regions Financial Corp | Ritter William D. | SEVP | S - Sale | $28.78 | -36,000 | 18,960 | -66% | -$1,036,062 | ||||||
2026-01-22 | DRI | Darden Restaurants Inc | King Sarah H. | SVP, Chief People Officer | S - Sale | $206.65 | -4,605 | 671 | -87% | -$951,636 | ||||||
2026-01-26 | HFWA | Heritage Financial Corp /Wa/ | Wilson Kelli Ann | EVP Chief Banking Officer | S - Sale | $26.48 | -1,900 | 3,778 | -33% | -$50,307 | ||||||
2026-01-22 | ABEO | Abeona Therapeutics Inc. | Vasanthavada Madhav | Chief Commercial Officer | S - Sale | $5.29 | -12,610 | 318,619 | -4% | -$66,658 | ||||||
2026-01-22 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Pres, COO | S - Sale | $18.10 | -3,828 | 210,164 | -2% | -$69,296 | ||||||
| D | 2026-01-22 | BCAX | Bicara Therapeutics Inc. | Hyep Ivan | CFO | S - Sale+OE | $18.15 | -1,882 | 145,355 | -1% | -$34,162 | |||||
2026-01-22 | URBN | Urban Outfitters Inc | Hayne Margaret | Co-Pres, CCO | S - Sale | $71.17 | -9,333 | 23,717,028 | 0% | -$664,222 | ||||||
2026-01-22 | URBN | Urban Outfitters Inc | Hayne Richard A | CEO, COB, 10% | S - Sale | $71.17 | -20,000 | 23,717,028 | 0% | -$1,423,383 | ||||||
2026-01-23 | HWC | Hancock Whitney Corp | Ziluca Christopher S | Chief Credit Officer | S - Sale | $68.57 | -5,227 | 33,301 | -14% | -$358,415 | ||||||
| D | 2026-01-23 | TRV | Travelers Companies, Inc. | Klenk Jeffrey P. | EVP, Pres, Bond, Spec. Ins. | S - Sale+OE | $279.78 | -16,712 | 6,075 | -73% | -$4,675,593 | |||||
2026-01-23 | ACN | Accenture Plc | Unruch Joel | GC, Corp Secretary | S - Sale | $281.70 | -1,026 | 27,181 | -4% | -$289,024 | ||||||
| M | 2026-01-22 | PATH | Uipath, Inc. | Dines Daniel | CEO, COB, 10% | S - Sale | $15.09 | -135,000 | 37,508,882 | 0% | -$2,037,227 | |||||
2026-01-22 | CRDO | Credo Technology Group Holding Ltd | Cheng Chi Fung | CTO | S - Sale | $136.33 | -30,000 | 6,438,590 | 0% | -$4,089,941 | ||||||
| D | 2026-01-22 | FWRG | First Watch Restaurant Group, Inc. | Kussell William A | Dir | S - Sale+OE | $17.00 | -6,165 | 26,402 | -19% | -$104,805 | |||||
2026-01-23 | RPRX | Royalty Pharma Plc | Urist Marshall | EVP, Research, Investments | S - Sale | $40.26 | -20,000 | 46,418 | -30% | -$805,110 | ||||||
| D | 2026-01-22 | MAZE | Maze Therapeutics, Inc. | Bachrodt Amy | SVP, Finance | S - Sale+OE | $45.52 | -5,000 | 12,965 | -28% | -$227,612 | |||||
2026-01-22 | SMTC | Semtech Corp | Silberstein Asaf | EVP, COO | S - Sale | $83.00 | -5,000 | 88,496 | -5% | -$415,000 | ||||||
2026-01-22 | BEAM | Beam Therapeutics Inc. | Cavanagh Bethany J | SVP, Finance, Treasurer | S - Sale | $35.00 | -6,198 | 34,813 | -15% | -$216,933 | ||||||
2026-01-22 | BEAM | Beam Therapeutics Inc. | Bellon Christine | GC | S - Sale | $34.00 | -1,371 | 95,667 | -1% | -$46,614 | ||||||
2026-01-22 | MCHP | Microchip Technology Inc | Sanghi Steve | Pres, CEO, Chair of Bd | S - Sale | $79.20 | -18,509 | 10,021,133 | 0% | -$1,465,883 | ||||||
2026-01-22 | AEHR | Aehr Test Systems | Oliphant Laura | Dir | S - Sale | $31.40 | -4,546 | 26,097 | -15% | -$142,750 | ||||||
| D | 2026-01-23 | PG | Procter & Gamble Co | Pritchard Marc S. | Chief Brand Officer | S - Sale+OE | $151.15 | -95,903 | 231,811 | -29% | -$14,495,690 | |||||
2026-01-22 | BOKF | Bok Financial Corp | Bangert Steven | Dir | S - Sale | $137.78 | -3,800 | 45,852 | -8% | -$523,558 | ||||||
| M | 2026-01-22 | ECAT | Blackrock Esg Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% | S - Sale | $15.50 | -94,044 | 25,704,244 | 0% | -$1,457,682 | |||||
2026-01-23 | STEX | Streamex Corp. | Williams Mitchell Young | Chief Investment Officer | P - Purchase | $3.03 | +51,511 | 1,051,511 | +5% | +$155,852 | ||||||
2026-01-23 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Dir | P - Purchase | $3.13 | +41,000 | 48,000 | +586% | +$128,486 | ||||||
2026-01-23 | RCG | Renn Fund, Inc. | Stahl Murray | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.70 | +1,134 | 1,019,962 | 0% | +$3,062 | ||||||
2026-01-23 | TPL | Texas Pacific Land Corp | Horizon Kinetics Asset Management LLC | 10% | P - Purchase | $350.06 | +1 | 3,487,698 | 0% | +$350 | ||||||
2026-01-22 | PFG | Principal Financial Group Inc | Strable-Soethout Deanna D | Pres, CEO | S - Sale | $92.56 | -8,025 | 54,227 | -13% | -$742,794 | ||||||
2026-01-23 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.50 | +90,325 | 8,182,120 | +1% | +$45,000 | ||||||
| M | 2026-01-22 | TAYD | Taylor Devices, Inc. | Armenat Fritz Eric | Dir | S - Sale | $71.95 | -4,328 | 0 | -100% | -$311,387 | |||||
| D | 2026-01-23 | HAL | Halliburton Co | Miller Jeffrey Allen | Dir, Pres, CEO | S - Sale+OE | $34.96 | -171,200 | 1,101,243 | -13% | -$5,985,152 | |||||
| D | 2026-01-23 | HAL | Halliburton Co | Beckwith Van H. | EVP, Secretary, CLO | S - Sale+OE | $34.96 | -54,348 | 344,535 | -14% | -$1,900,006 | |||||
2026-01-26 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.52 | +1,243 | 106,904 | +1% | +$1,889 | ||||||
2026-01-22 | BDSX | Biodesix Inc | Schuler Jack W | Emeritus Director, 10% | P - Purchase | $10.96 | +82,465 | 2,213,210 | +4% | +$903,561 | ||||||
| AM | 2026-01-16 | AVO | Mission Produce, Inc. | Globalharvest Holdings Venture Ltd | 10% | P - Purchase | $12.43 | +624,302 | 9,461,588 | +7% | +$7,761,616 | |||||
| M | 2026-01-21 | AVO | Mission Produce, Inc. | Globalharvest Holdings Venture Ltd | 10% | P - Purchase | $13.12 | +309,020 | 9,770,608 | +3% | +$4,055,678 | |||||
2026-01-23 | GME | Gamestop Corp. | Cheng Lawrence | Dir | P - Purchase | $22.87 | +5,000 | 88,000 | +6% | +$114,369 | ||||||
2026-01-23 | PFBX | Peoples Financial Corp /Ms/ | Stilwell Joseph | 10% | P - Purchase | $20.50 | +1,840 | 692,952 | 0% | +$37,720 | ||||||
| M | 2026-01-22 | TG | Tredegar Corp | Gottwald William M | 10% | S - Sale | $8.64 | -79,092 | 1,705,919 | -4% | -$683,494 | |||||
| M | 2026-01-22 | TG | Tredegar Corp | Gottwald James T. | 10% | S - Sale | $8.64 | -79,092 | 1,628,461 | -5% | -$683,494 | |||||
| M | 2026-01-22 | TG | Tredegar Corp | Gottwald John D | 10% | S - Sale | $8.64 | -79,092 | 3,509,054 | -2% | -$683,494 | |||||
2026-01-22 | CVM | Cel Sci Corp | Kersten Geert R | CEO | P - Purchase | $5.26 | +38,023 | 120,815 | +46% | +$200,001 | ||||||
2026-01-23 | ABT | Abbott Laboratories | Ford Robert B | COB, CEO | P - Purchase | $107.13 | +18,800 | 469,508 | +4% | +$2,013,967 | ||||||
| M | 2026-01-20 | NYC | American Strategic Investment Co. | Schorsch Nicholas S | 10% | P - Purchase | $10.57 | +5,460 | 1,614,517 | 0% | +$57,726 | |||||
| D | 2026-01-22 | SCHW | Schwab Charles Corp | Beatty Jonathan S | MD, Head of Advisor Services | S - Sale+OE | $105.00 | -2,000 | 55,263 | -3% | -$210,003 | |||||
| D | 2026-01-21 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $124.65 | -4,502 | 92,366 | -5% | -$561,174 | |||||
2026-01-23 | DC | Dakota Gold Corp. | Quartermain Robert | CEO | S - Sale | $6.88 | -250,000 | 7,493,244 | -3% | -$1,720,875 | ||||||
| M | 2026-01-21 | PCOR | Procore Technologies, Inc. | O Connor Kevin J | Dir | S - Sale | $63.98 | -15,384 | 1,044,152 | -1% | -$984,269 | |||||
| D | 2026-01-22 | QTIH | Qt Imaging Holdings, Inc. | Katz Avi S | COB | P - Purchase | $6.43 | +24,107 | 413,452 | +6% | +$155,008 | |||||
2026-01-21 | GOOGL | Alphabet Inc. | Pichai Sundar | CEO | S - Sale | $327.30 | -32,500 | 2,439,432 | -1% | -$10,637,368 | ||||||
| M | 2026-01-22 | WRB | Berkley W R Corp | Mitsui Sumitomo Insurance Co Ltd | 10% | P - Purchase | $67.19 | +698,000 | 54,589,504 | +1% | +$46,898,492 | |||||
2026-01-23 | CENX | Century Aluminum Co | Gary Jesse E | Pres, CEO | S - Sale | $48.19 | -150,000 | 569,807 | -21% | -$7,228,500 | ||||||
| D | 2026-01-21 | DC | Dakota Gold Corp. | Campbell Shawn | CFO | S - Sale+OE | $6.30 | -55,000 | 500,851 | -10% | -$346,291 | |||||
| D | 2026-01-22 | AXSM | Axsome Therapeutics, Inc. | Pizzie Nick | CFO | S - Sale+OE | $187.92 | -12,000 | 43,076 | -22% | -$2,255,040 | |||||
| D | 2026-01-21 | AXSM | Axsome Therapeutics, Inc. | Maizel Ari | Chief Commercial Officer | S - Sale+OE | $184.44 | -7,500 | 0 | -100% | -$1,383,300 | |||||
| D | 2026-01-21 | BLK | Blackrock, Inc. | Kushel J. Richard | Senior MD | S - Sale+OE | $1,125.00 | -20,000 | 141,072 | -12% | -$22,500,000 | |||||
2026-01-21 | PTON | Peloton Interactive, Inc. | Kirol Charles Peter | COO | S - Sale | $5.85 | -3,399 | 77,602 | -4% | -$19,895 | ||||||
| M | 2026-01-21 | ACR | Acres Commercial Realty Corp. | Eagle Point Credit Management LLC | 10% | S - Sale | $22.04 | -1,792 | 2,289,089 | 0% | -$39,494 | |||||
2026-01-22 | MTB | M&T Bank Corp | Barnes John P | Dir | S - Sale | $220.81 | -17,866 | 36,335 | -33% | -$3,945,054 | ||||||
| A | 2026-01-20 | CMU | Mfs High Yield Municipal Trust | Bulldog Investors, LLP | 10% | P - Purchase | $3.50 | +678 | 24,878 | +3% | +$2,373 | |||||
2026-01-21 | PL | Planet Labs Pbc | Robinson Kristen | Dir | S - Sale | $26.96 | -47,835 | 260,004 | -16% | -$1,289,632 | ||||||
| DM | 2026-01-22 | SES | Ses Ai Corp | Gan Hong | Chief Science Officer | S - Sale+OE | $2.50 | -250,000 | 1,253,286 | -17% | -$624,705 | |||||
2026-01-22 | PL | Planet Labs Pbc | Gadde Vijaya | Dir | S - Sale | $26.77 | -20,000 | 250,169 | -7% | -$535,350 | ||||||
2026-01-22 | LIND | Lindblad Expeditions Holdings, Inc. | Lindblad Sven-Olof | Dir, 10% | S - Sale | $16.48 | -62,100 | 11,566,028 | -1% | -$1,023,203 | ||||||
2026-01-22 | TEAM | Atlassian Corp | Cannon-Brookes Michael | CEO, Co-Founder, 10% | S - Sale | $126.11 | -7,665 | 360,255 | -2% | -$966,640 | ||||||
2026-01-22 | TEAM | Atlassian Corp | Farquhar Scott | Dir, 10% | S - Sale | $126.11 | -7,665 | 360,255 | -2% | -$966,641 | ||||||
| M | 2026-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | GC, Corp Sec | S - Sale | $1.87 | -8,934 | 173,999 | -5% | -$16,721 | |||||
| M | 2026-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | Siemers Eric | Chief Medical Officer | S - Sale | $1.81 | -3,226 | 255,371 | -1% | -$5,833 | |||||
| M | 2026-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | CFO, Chief Business Officer | S - Sale | $1.83 | -4,160 | 304,924 | -1% | -$7,607 | |||||
| M | 2026-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | Oconnell Daniel Joseph | CEO | S - Sale | $1.83 | -12,035 | 881,275 | -1% | -$21,993 | |||||
| M | 2026-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | Barton Russell | COO | S - Sale | $1.81 | -2,777 | 205,092 | -1% | -$5,031 | |||||
| A | 2025-12-30 | AMBA | Ambarella Inc | Ju Chi-Hong | SVP, Systems, GM, Asia | S - Sale | $70.25 | -7,945 | 149,587 | -5% | -$558,136 | |||||
| D | 2026-01-22 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale+OE | $11.50 | -1,201 | 164,458 | -1% | -$13,812 | |||||
| M | 2026-01-21 | LXU | Lsb Industries, Inc. | Golsen Barry H | Dir | S - Sale | $10.05 | -118,980 | 141,544 | -46% | -$1,196,201 | |||||
| M | 2026-01-21 | CDNA | Caredx, Inc. | Hanna John Walter Jr | Pres, CEO | S - Sale | $21.16 | -19,480 | 597,405 | -3% | -$412,223 | |||||
2026-01-22 | IONS | Ionis Pharmaceuticals Inc | Devers Shannon L. | EVP, Chief HR Ofc | S - Sale | $81.34 | -3,977 | 22,541 | -15% | -$323,490 | ||||||
2026-01-22 | WMT | Walmart Inc. | McMillon C Douglas | Pres, CEO | S - Sale | $119.17 | -19,416 | 5,334,561 | 0% | -$2,313,875 | ||||||
| M | 2026-01-22 | SLGL | Sol-Gel Technologies Ltd. | Opaleye Management Inc. | 10% | P - Purchase | $56.36 | +3,324 | 459,844 | +1% | +$187,356 | |||||
| DM | 2026-01-21 | AMPX | Amprius Technologies, Inc. | Stefan Constantin Ionel | CTO | S - Sale+OE | $12.03 | -567,707 | 748,696 | -43% | -$6,830,523 | |||||
2026-01-23 | PLNH | Planet 13 Holdings Inc. | Wren Chris | VP of Operations | S - Sale | $0.19 | -30,000 | 3,873,287 | -1% | -$5,571 | ||||||
2026-01-21 | RNA | Avidity Biosciences, Inc. | Hughes Steven George | Chief Medical Officer | S - Sale | $72.45 | -4,895 | 31,599 | -13% | -$354,643 | ||||||
2026-01-21 | RNA | Avidity Biosciences, Inc. | Boyce Sarah | Pres, CEO | S - Sale | $72.45 | -14,387 | 269,007 | -5% | -$1,042,338 | ||||||
2026-01-21 | RNA | Avidity Biosciences, Inc. | Flanagan W. Michael | Chief Scientific Officer | S - Sale | $72.45 | -6,534 | 85,093 | -7% | -$473,388 | ||||||
2026-01-21 | RNA | Avidity Biosciences, Inc. | Maclean Michael F | CFO | S - Sale | $72.45 | -4,542 | 59,290 | -7% | -$329,068 | ||||||
2026-01-21 | RNA | Avidity Biosciences, Inc. | Levin Arthur A | Dir | S - Sale | $72.45 | -1,758 | 170,434 | -1% | -$127,367 | ||||||
2026-01-21 | RNA | Avidity Biosciences, Inc. | McCarthy Teresa | CHRO | S - Sale | $72.45 | -2,929 | 113,938 | -3% | -$212,206 | ||||||
| M | 2026-01-22 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% | S - Sale | $5.30 | -18,221 | 599,603 | -3% | -$96,658 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |